Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity
- PMID: 19457123
- DOI: 10.1111/j.1471-4159.2009.06131.x
Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity
Abstract
Amyloid-beta (Abeta) peptides production is thought to be a key event in the neurodegenerative process ultimately leading to Alzheimer's disease (AD) pathology. A bulk of studies concur to propose that the C-terminal moiety of Abeta is released from its precursor beta-amyloid precursor protein by a high molecular weight enzymatic complex referred to as gamma-secretase, that is composed of at least, nicastrin (NCT), Aph-1, Pen-2, and presenilins (PS) 1 or 2. They are thought to harbor the gamma-secretase catalytic activity. However, several lines of evidence suggest that additional gamma-secretase-like activities could potentially contribute to Abeta production. By means of a quenched fluorimetric substrate (JMV2660) mimicking the beta-amyloid precursor protein sequence targeted by gamma-secretase, we first show that as expected, this probe allows monitoring of an activity detectable in several cell systems including the neuronal cell line telencephalon specific murine neurons (TSM1). This activity is reduced by DFK167, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), and LY68458, three inhibitors known to functionally interact with PS. Interestingly, JMV2660 but not the unrelated peptide JMV2692, inhibits Abeta production in an in vitrogamma-secretase assay as expected from a putative substrate competitor. This activity is enhanced by PS1 and PS2 mutations known to be responsible for familial forms of AD and reduced by aspartyl mutations inactivating PS or in cells devoid of PS or NCT. However, we clearly establish that residual JMV2660-hydrolysing activity could be recovered in PS- and NCT-deficient fibroblasts and that this activity remained inhibited by DFK167. Overall, our study describes the presence of a proteolytic activity displaying gamma-secretase-like properties but independent of PS and still blocked by DFK167, suggesting that the PS-dependent complex could not be the unique gamma-secretase activity responsible for Abeta production and delineates PS-independent gamma-secretase activity as a potential additional therapeutic target to fight AD pathology.
Similar articles
-
Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes.Neurobiol Dis. 2007 Jul;27(1):102-7. doi: 10.1016/j.nbd.2007.04.011. Epub 2007 May 6. Neurobiol Dis. 2007. PMID: 17560791
-
PEN-2 enhances gamma-cleavage after presenilin heterodimer formation.J Neurochem. 2004 Sep;90(6):1402-13. doi: 10.1111/j.1471-4159.2004.02597.x. J Neurochem. 2004. PMID: 15341524
-
Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin: identification of nicastrin mutants that selectively interact with APH-1.J Neurochem. 2004 Jun;89(6):1520-7. doi: 10.1111/j.1471-4159.2004.02447.x. J Neurochem. 2004. PMID: 15189355
-
The Alzheimer's disease-associated gamma-secretase complex: functional domains in the presenilin 1 protein.Physiol Behav. 2007 Sep 10;92(1-2):115-20. doi: 10.1016/j.physbeh.2007.05.037. Epub 2007 May 21. Physiol Behav. 2007. PMID: 17588625 Review.
-
Presenilin function and gamma-secretase activity.J Neurochem. 2005 May;93(4):769-92. doi: 10.1111/j.1471-4159.2005.03099.x. J Neurochem. 2005. PMID: 15857382 Review.
Cited by
-
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease.Cell Mol Life Sci. 2016 Jan;73(1):217-36. doi: 10.1007/s00018-015-1992-1. Epub 2015 Jul 23. Cell Mol Life Sci. 2016. PMID: 26202697 Free PMC article.
-
Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?J Biol Chem. 2018 Oct 5;293(40):15419-15428. doi: 10.1074/jbc.R118.003999. Epub 2018 Aug 24. J Biol Chem. 2018. PMID: 30143530 Free PMC article. Review.
-
Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.J Neurosci. 2012 Aug 22;32(34):11820-34. doi: 10.1523/JNEUROSCI.0875-12.2012. J Neurosci. 2012. PMID: 22915123 Free PMC article.
-
α-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid β (Aβ)-associated cell death.J Biol Chem. 2012 Feb 10;287(7):5021-32. doi: 10.1074/jbc.M111.323626. Epub 2011 Dec 19. J Biol Chem. 2012. PMID: 22184125 Free PMC article.
-
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease.EBioMedicine. 2016 Jul;9:278-292. doi: 10.1016/j.ebiom.2016.06.002. Epub 2016 Jun 2. EBioMedicine. 2016. PMID: 27333034 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases